scispace - formally typeset
D

David B. Rosen

Researcher at University of California, San Francisco

Publications -  17
Citations -  2856

David B. Rosen is an academic researcher from University of California, San Francisco. The author has contributed to research in topics: Receptor & Medicine. The author has an hindex of 11, co-authored 13 publications receiving 2602 citations.

Papers
More filters
Journal ArticleDOI

CD69 acts downstream of interferon-alpha/beta to inhibit S1P1 and lymphocyte egress from lymphoid organs.

TL;DR: Treatment with the IFN-α/β inducer polyinosine polycytidylic acid inhibited egress by a mechanism that was partly lymphocyte-intrinsic, and observations indicate that CD69 forms a complex with and negatively regulates S1P1 and that it functions downstream ofIFN- α/β, and possibly other activating stimuli, to promote lymphocyte retention in lymphoid organs.
Journal ArticleDOI

Cutting edge: lectin-like transcript-1 is a ligand for the inhibitory human NKR-P1A receptor

TL;DR: In this article, the lectin-like transcript-1 (LLT1) is shown to be a physiologic ligand for NKR-P1A, and LLT1-containing liposomes bind to NKRp1A + cells, and binding is inhibited by anti-NKR-p1a mAb.

Cutting Edge: Lectin-Like Transcript-1 Is a Ligand for the Inhibitory Human NKR-P1A Receptor 1

TL;DR: It is demonstrated that the lectin-like transcript-1 (LLT1) is a physiologic ligand for NKR-P1A, a C-type lectin receptors present on NK cells and subsets of T cells.
Journal ArticleDOI

Plasmacytoid dendritic cell–specific receptor ILT7–FcεRIγ inhibits Toll-like receptor–induced interferon production

TL;DR: It is demonstrated here that ILT7 protein associates with the signal adapter protein FcɛRIγ to form a receptor complex that negatively regulates the innate immune functions of human pDCs.